Featured Insights and Perspectives from Darwin

The latest insights, ideas, and perspectives from Darwin, updated weekly. Explore a cross-section of up-to-date content from us and other thought leaders on trends in health care, research, and data.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

News and Insights

Showing items 1 to3 of 6

Topics
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
HealthPartners, Essentia Health agree to combine amid persistent increase in health system M&A activity
Insight
Our Take Newsletter
October 5, 2026

HealthPartners, Essentia Health agree to combine amid persistent increase in health system M&A activity

Learn More
October 5, 2026
Health policy, CMS initiatives and health economics
IDN trends, challenges, and leadership
Telix to merge with ITM in deal worth up to $2.35 billion
Insight
Our Take Newsletter
September 28, 2026

Telix to merge with ITM in deal worth up to $2.35 billion

Learn More
September 28, 2026
Digital health and emerging technologies
FDA approves first treatment targeting muscle loss in spinal muscular atrophy
Insight
Our Take Newsletter
September 21, 2026

FDA approves first treatment targeting muscle loss in spinal muscular atrophy

Learn More
September 21, 2026
Pharma strategy, engagement, and market access
OpenAI announces integration of ChatGPT for Healthcare with Epic’s EHR
Insight
Our Take Newsletter
September 14, 2026

OpenAI announces integration of ChatGPT for Healthcare with Epic’s EHR

Learn More
September 14, 2026
Digital health and emerging technologies
FDA grants momentous approval in pancreatic cancer
Insight
Our Take Newsletter
August 31, 2026

FDA grants momentous approval in pancreatic cancer

Learn More
August 31, 2026
Pharmacy, PBMs and drug pricing
Pharma strategy, engagement, and market access
Moderna, Merck announce positive Phase III trial results for personalized mRNA cancer therapy
Insight
Our Take Newsletter
August 24, 2026

Moderna, Merck announce positive Phase III trial results for personalized mRNA cancer therapy

Learn More
August 24, 2026
Pharmacy, PBMs and drug pricing
Trump tries again to revise federal childhood vaccination recommendations
Insight
Our Take Newsletter
August 17, 2026

Trump tries again to revise federal childhood vaccination recommendations

Learn More
August 17, 2026
Pharmacy, PBMs and drug pricing
Summa Health names new CEO to lead next phase of HATCo's health assurance vision
Insight
Our Take Newsletter
August 10, 2026

Summa Health names new CEO to lead next phase of HATCo's health assurance vision

Learn More
August 10, 2026
IDN trends, challenges, and leadership
Loss of ‘enhanced’ ACA subsidies hits IDNs harder than expected
Insight
Our Take Newsletter
August 3, 2026

Loss of ‘enhanced’ ACA subsidies hits IDNs harder than expected

Learn More
August 3, 2026
IDN trends, challenges, and leadership
A look at four IDN M&A strategies
Insight
Our Take Newsletter
July 27, 2026

A look at four IDN M&A strategies

Learn More
July 27, 2026
IDN trends, challenges, and leadership
CMS releases new ACO REACH data
Insight
Our Take Newsletter
July 20, 2026

CMS releases new ACO REACH data

Learn More
July 20, 2026
Health policy, CMS initiatives and health economics
Vertex’s acquisition of Crinetics tops the latest spree of deals
Insight
Our Take Newsletter
July 13, 2026

Vertex’s acquisition of Crinetics tops the latest spree of deals

Learn More
July 13, 2026
IDN trends, challenges, and leadership
Stay Aware. Stay Informed.

Want to stay ahead of health care trends?

Sign up for highly curated, expert weekly strategic insights for health care executives and leaders.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.